• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 Transformer-Decoder GPT 模型的 HMG-CoA 还原酶抑制剂虚拟筛选库生成:温度、提示长度和迁移学习策略的影响。

Transformer-Decoder GPT Models for Generating Virtual Screening Libraries of HMG-Coenzyme A Reductase Inhibitors: Effects of Temperature, Prompt Length, and Transfer-Learning Strategies.

机构信息

School of Chemistry, Food and Pharmacy, University of Reading, Reading RG6 6AD, U.K.

出版信息

J Chem Inf Model. 2024 Nov 25;64(22):8464-8480. doi: 10.1021/acs.jcim.4c01309. Epub 2024 Nov 7.

DOI:10.1021/acs.jcim.4c01309
PMID:39509180
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11600504/
Abstract

Attention-based decoder models were used to generate libraries of novel inhibitors for the HMG-Coenzyme A reductase (HMGCR) enzyme. These deep neural network models were pretrained on previously synthesized drug-like molecules from the ZINC15 database to learn the syntax of SMILES strings and then fine-tuned with a set of ∼1000 molecules that inhibit HMGCR. The number of layers used for pretraining and fine-tuning was varied to find the optimal balance for robust library generation. Virtual screening libraries were also generated with different temperatures and numbers of input tokens (prompt length) to find the most desirable molecular properties. The resulting libraries were screened against several criteria, including IC50 values predicted by a dense neural network (DNN) trained on experimental HMGCR IC50 values, docking scores from AutoDock Vina (via Dockstring), a calculated quantitative estimate of druglikeness, and Tanimoto similarity to known HMGCR inhibitors. It was found that 50/50 or 25/75% pretrained/fine-tuned models with a nonzero temperature and shorter prompt lengths produced the most robust libraries, and the DNN-predicted IC50 values had good correlation with docking scores and statin similarity. 42% of generated molecules were classified as statin-like by k-means clustering, with the rosuvastatin-like group having the lowest IC50 values and lowest docking scores.

摘要

基于注意力的解码器模型被用于生成 HMG-Coenzyme A 还原酶(HMGCR)酶的新型抑制剂文库。这些深度神经网络模型在先前从 ZINC15 数据库中合成的类似药物的分子上进行了预训练,以学习 SMILES 字符串的语法,然后使用一组约 1000 个抑制 HMGCR 的分子进行微调。用于预训练和微调的层数有所不同,以找到稳健的文库生成的最佳平衡点。还使用不同的温度和输入标记数量(提示长度)生成虚拟筛选文库,以找到最理想的分子性质。根据几个标准对生成的文库进行筛选,包括基于实验 HMGCR IC50 值训练的密集神经网络(DNN)预测的 IC50 值、AutoDock Vina 的对接分数(通过 Dockstring)、计算得出的药物相似性定量估计以及与已知 HMGCR 抑制剂的 Tanimoto 相似性。结果发现,50/50 或 25/75%的预训练/微调模型,温度不为零且提示长度较短,产生的文库最稳健,DNN 预测的 IC50 值与对接分数和他汀类药物相似性具有良好的相关性。通过 K 均值聚类,有 42%的生成分子被归类为他汀类药物,其中瑞舒伐他汀类药物的 IC50 值最低,对接分数也最低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d65e/11600504/d65ec89a518f/ci4c01309_0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d65e/11600504/4c5d5f314b33/ci4c01309_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d65e/11600504/5e7d0d4748c9/ci4c01309_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d65e/11600504/ee605ce8d945/ci4c01309_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d65e/11600504/d0c62da34e00/ci4c01309_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d65e/11600504/ee4dd8b88ed0/ci4c01309_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d65e/11600504/76efb6ba4fdd/ci4c01309_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d65e/11600504/44aee9d8f775/ci4c01309_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d65e/11600504/9b1a65f0bfdc/ci4c01309_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d65e/11600504/faed387ffc4c/ci4c01309_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d65e/11600504/0826b9cafad2/ci4c01309_0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d65e/11600504/d65ec89a518f/ci4c01309_0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d65e/11600504/4c5d5f314b33/ci4c01309_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d65e/11600504/5e7d0d4748c9/ci4c01309_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d65e/11600504/ee605ce8d945/ci4c01309_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d65e/11600504/d0c62da34e00/ci4c01309_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d65e/11600504/ee4dd8b88ed0/ci4c01309_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d65e/11600504/76efb6ba4fdd/ci4c01309_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d65e/11600504/44aee9d8f775/ci4c01309_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d65e/11600504/9b1a65f0bfdc/ci4c01309_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d65e/11600504/faed387ffc4c/ci4c01309_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d65e/11600504/0826b9cafad2/ci4c01309_0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d65e/11600504/d65ec89a518f/ci4c01309_0011.jpg

相似文献

1
Transformer-Decoder GPT Models for Generating Virtual Screening Libraries of HMG-Coenzyme A Reductase Inhibitors: Effects of Temperature, Prompt Length, and Transfer-Learning Strategies.基于 Transformer-Decoder GPT 模型的 HMG-CoA 还原酶抑制剂虚拟筛选库生成:温度、提示长度和迁移学习策略的影响。
J Chem Inf Model. 2024 Nov 25;64(22):8464-8480. doi: 10.1021/acs.jcim.4c01309. Epub 2024 Nov 7.
2
Use of virtual screening, flexible docking, and molecular interaction fields to design novel HMG-CoA reductase inhibitors for the treatment of hypercholesterolemia.利用虚拟筛选、柔性对接和分子相互作用场设计新型HMG-CoA还原酶抑制剂用于治疗高胆固醇血症。
J Phys Chem A. 2008 Mar 13;112(10):2007-11. doi: 10.1021/jp075502e. Epub 2007 Nov 29.
3
Exploration of natural product ingredients as inhibitors of human HMG-CoA reductase through structure-based virtual screening.通过基于结构的虚拟筛选探索天然产物成分作为人HMG-CoA还原酶抑制剂的研究。
Drug Des Devel Ther. 2015 Jun 26;9:3313-24. doi: 10.2147/DDDT.S84641. eCollection 2015.
4
Novel synthetic inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase activity that inhibit tumor cell proliferation and are structurally unrelated to existing statins.新型3-羟基-3-甲基戊二酰辅酶A(HMG-CoA)还原酶活性抑制剂,可抑制肿瘤细胞增殖,且在结构上与现有他汀类药物无关。
Int J Mol Med. 2009 Nov;24(5):633-43. doi: 10.3892/ijmm_00000274.
5
Explication of interactions between HMGCR isoform 2 and various statins through In silico modeling and docking.通过计算机建模和对接技术解析 HMGCR 同种型 2 与各种他汀类药物的相互作用。
Comput Biol Med. 2012 Feb;42(2):156-63. doi: 10.1016/j.compbiomed.2011.11.003. Epub 2011 Dec 15.
6
Discriminating of HMG-CoA reductase inhibitors and decoys using self-organizing maps.使用自组织映射区分 HMG-CoA 还原酶抑制剂和诱饵。
Mol Divers. 2011 Aug;15(3):655-63. doi: 10.1007/s11030-010-9288-8. Epub 2010 Nov 12.
7
Human hydroxymethylglutaryl-coenzyme A reductase (HMGCR) and statin sensitivity.人类羟甲基戊二酰辅酶A还原酶(HMGCR)与他汀类药物敏感性。
Indian J Biochem Biophys. 2010 Dec;47(6):331-9.
8
Exploration of virtual candidates for human HMG-CoA reductase inhibitors using pharmacophore modeling and molecular dynamics simulations.运用类药性建模和分子动力学模拟技术探索人 HMG-CoA 还原酶抑制剂的虚拟候选物。
PLoS One. 2013 Dec 30;8(12):e83496. doi: 10.1371/journal.pone.0083496. eCollection 2013.
9
A-family anti-inflammatory cyclopentenone prostaglandins: A novel class of non-statin inhibitors of HMG-CoA reductase.A 族抗炎环戊烯酮前列腺素:一种新型 HMG-CoA 还原酶非他汀类抑制剂。
Biochimie. 2021 Mar;182:37-50. doi: 10.1016/j.biochi.2020.12.019. Epub 2021 Jan 4.
10
In-silico HMG-CoA reductase-inhibitory and in-vivo anti-lipidaemic/anticancer effects of carotenoids from Spondias mombin.从杧果中提取的类胡萝卜素的计算机模拟 HMG-CoA 还原酶抑制作用和体内抗脂质/抗癌作用。
J Pharm Pharmacol. 2021 Sep 7;73(10):1377-1386. doi: 10.1093/jpp/rgab103.